McAndrew Natalie S, Wallace Lyndsey, Guttormson Jill, McCracken Colleen, Olex Maria, Banerjee Anjishnu, Visotcky Alexis, Bartowitz Jennifer, Seaman Jennifer B, Knight Jennifer M, Ferrell Betty, El-Jawahri Areej, Applebaum Allison J
School of Nursing and Department of Patient Care Research, University of Wisconsin-Milwaukee and Froedtert Hospital, Milwaukee, Wisconsin, USA.
Department of Psychiatry and Behavioral Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
Psychooncology. 2025 Apr;34(4):e70142. doi: 10.1002/pon.70142.
Family caregivers of patients undergoing hematopoietic stem cell transplantation (HSCT) experience significant challenges (e.g., witnessing suffering and experiencing loss and uncertainty) that contribute to existential distress and poor psychosocial outcomes. Meaning-Centered Psychotherapy for Cancer Caregivers (MCP-C) is a palliative-based intervention that targets existential distress by helping caregivers connect to sources of meaning in their lives.
Test the feasibility and acceptability of nurse-delivered Meaning-Centered Psychotherapy for Cancer Caregivers (MCP-C) for caregivers of hematopoietic stem cell transplantation (HSCT) recipients.
Single-arm pilot trial of 7-session palliative-based intervention delivered via Zoom/telephone. We enrolled 32 caregivers of adult autologous/allogeneic HSCT recipients at a tertiary care academic center. Feasibility was assessed by (1) ability to recruit 32 caregivers within the 20-month study enrollment period, (2) percentage who consented, (3) completed 4 or more intervention sessions, and (4) percentage who remained on study. Acceptability of MCP-C was assessed with Likert scale items and through exit interviews.
We approached 90 caregivers in 11 months to recruit target sample of 32; 90.6% (n = 29) completed all sessions/assessments; 96% (n = 31) met benchmark of 4 sessions. In exit interviews (n = 22), participants endorsed the (1) value of MCP-C, (2) nurse interventionist's knowledge of transplant care, and (3) convenience of telehealth delivery.
Nurse-delivered MCP-C via telehealth is feasible and acceptable for caregivers of HSCT recipients. A future randomized controlled trial is needed to fully evaluate the intervention's effect on caregiver outcomes.
接受造血干细胞移植(HSCT)患者的家庭照顾者面临重大挑战(例如,目睹患者痛苦、经历丧失和不确定性),这些挑战会导致存在性痛苦和不良的心理社会结果。癌症照顾者意义疗法(MCP-C)是一种基于姑息治疗的干预措施,通过帮助照顾者与生活中的意义来源建立联系来解决存在性痛苦。
测试由护士提供的癌症照顾者意义疗法(MCP-C)对造血干细胞移植(HSCT)受者照顾者的可行性和可接受性。
通过Zoom/电话进行为期7节的基于姑息治疗的单臂试点试验。我们在一家三级医疗学术中心招募了32名成年自体/异体HSCT受者的照顾者。可行性通过以下方面进行评估:(1)在20个月的研究招募期内招募32名照顾者的能力;(2)同意参与的百分比;(3)完成4节或更多干预课程的百分比;(4)留在研究中的百分比。通过李克特量表项目和退出访谈评估MCP-C的可接受性。
在11个月内我们接触了90名照顾者以招募32名目标样本;90.6%(n = 29)完成了所有课程/评估;96%(n = 31)达到了4节课程的基准。在退出访谈(n = 22)中,参与者认可了(1)MCP-C的价值;(2)护士干预者对移植护理的知识;(3)远程医疗服务的便利性。
通过远程医疗由护士提供MCP-C对HSCT受者的照顾者来说是可行且可接受的。未来需要进行随机对照试验来全面评估该干预措施对照顾者结局的影响。